0 Commenti
0 condivisioni
2K Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Dynamics: Key Drivers and RestraintsFuture of Executive Summary Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market: Size and Share Dynamics CAGR Value The global chronic kidney disease - mineral bone disorders (CKD-MBD) treatment market size was valued at USD 2.39 billion in 2024 and is expected to reach USD 4.80 billion by 2032, at a CAGR of 9.09% during the forecast...0 Commenti 0 condivisioni 175 Views 0 Anteprima
-
Chronic Kidney Disease Drugs Market Size Projected to Reach USD 21.4 Billion by 2032“According to a new report published by Introspective Market Research, Chronic Kidney Disease Drugs Market by Drug Class, Distribution Channel, and End User, The Global Chronic Kidney Disease Drugs Market Size Was Valued at USD 14.8 Billion in 2023 and is Projected to Reach USD 21.4 Billion by 2032, Growing at a CAGR of 4.2% From 2024–2032.” The Chronic Kidney Disease (CKD)...0 Commenti 0 condivisioni 767 Views 0 Anteprima
-
Increasing Kidney Disease Cases Propel Growth of the Global Dialysis Concentrates MarketExecutive Summary Dialysis Concentrates Market Size and Share Forecast Data Bridge Market Research analyses that the dialysis concentrates market which was USD 2837.79 million in 2021, would rocket up to USD 4322.20 million by 2029, and is expected to undergo a CAGR of 5.40% during the forecast period 2022 to 2029. Dialysis Concentrates Market business report is a...0 Commenti 0 condivisioni 2K Views 0 Anteprima
-
Is the Global EPO Drugs Market Expanding With Rising Chronic Kidney Disease and Anemia Cases?Executive Summary Erythropoietin (EPO) Drugs Market Size and Share Forecast The global erythropoietin (EPO) drugs market size was valued at USD 9.12 billion in 2024 and is expected to reach USD 22.60 billion by 2032, at a CAGR of 12.00% during the forecast period The Erythropoietin (EPO) Drugs report also makes available CAGR value fluctuation...0 Commenti 0 condivisioni 409 Views 0 Anteprima
-
Kidney Disease Market Revenue Analysis: Growth, Share, Value, Scope, and Insights"Executive Summary Kidney Disease Market Size and Share Analysis Report CAGR Value The global kidney disease market was valued at USD 113.57 billion in 2024 and is expected to reach USD 174.29 billion by 2032. During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 5.50%, primarily driven by aging population. Accomplishment of...0 Commenti 0 condivisioni 2K Views 0 Anteprima
-
Polycystic Kidney Disease (PKD) Market Size, Share, Trends, Demand, Growth and Competitive OutlookPolycystic Kidney Disease (PKD) Market By Type (Autosomal Dominant Polycystic Kidney Disease, Autosomal Recessive Polycystic Kidney Disease, Others), Treatment (Medication, Surgery, Others), Diagnosis (Ultrasound, CT Scan, MRI Scan), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail...0 Commenti 0 condivisioni 473 Views 0 Anteprima
-
Polycystic Kidney Disease (PKD) Market Size, Share, Trends, Key Drivers, Growth and Opportunity AnalysisPolycystic Kidney Disease (PKD) Market By Type (Autosomal Dominant Polycystic Kidney Disease, Autosomal Recessive Polycystic Kidney Disease, Others), Treatment (Medication, Surgery, Others), Diagnosis (Ultrasound, CT Scan, MRI Scan), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail...0 Commenti 0 condivisioni 570 Views 0 Anteprima
© 2026 Connect Little
Italiano
Italiano
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek